Delivery Order 75N92019D00017-75N92019F00074
Award Date 12/19/18
Potential Completion Date 12/18/23
Potential Value $508K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $234,478 contract is for the Gene Therapy Resource Program (GTRP) Pharmacology and Toxicology Core Laboratory. It is a cost-plus-fixed-fee contract with a period of performance through June 30, 2024. Lovelace Biomedical Research Institute...
- This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Heart Lung and Blood Institute (NHLBI). The $1,609,194.07 contract is a Delivery Order under the Gene Therapy Resource Program (GTRP) to provide pharmacology/toxicology core laboratory services for a scientific project. This work supports the National Institutes of Health's research efforts in gene therapy. The contract does not have a set-aside...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit...
- This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
- This is a delivery order under the Gene Therapy Resource Program (GTRP) contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The GTRP contract provides pharmacology and toxicology core laboratory services to support gene therapy research and development. The $10,766 delivery order was awarded to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. Lovelace will provide...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit contract research organization. The $706,056 cost-plus-fixed-fee task order is for LBERI to provide pharmacology-toxicology core laboratory services in support of the GTRP (Gene Therapy Resource Program) during fiscal year 2014, with a period of performance from February...
- This federal contract award, valued at $1,013,722.26, was issued by the National Heart Lung and Blood Institute, a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The award is for the GTRP Pharmacology-Toxicology Core Lab, Task Order 6, Task Area B, with a period of performance through April 15, 2017. The contract is a cost-plus-fixed-fee delivery order, without a set-aside designation. LBERI, a...
- This is a $3,108,022.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA) to the Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The contract is for the characterization of a downstream gene therapeutic for the reparative treatment of severe fractures, with a period of performance from September 24, 2020 to November 23, 2021. This contract does not have a set-aside designation. Lovelace Biomedical...
- This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The $366,923 cost-plus-fixed-fee contract is for the efficacy and safety evaluation of a lead gene therapy candidate in methyl malonic acidemia (MMAB) disease mouse models, as well as the development of bioanalytical assay methods. The...